Coeptis Therapeutics, Inc. Stock-Based Compensation
Coeptis Therapeutics, Inc. reported Stock-Based Compensation of $0 for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2022-11-08
- Coeptis Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2021-12-31 was $0.00.
- Coeptis Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2020-12-31 was $0.00.
- Coeptis Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2020-11-30 was $479.00K.
- Coeptis Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2021 was $1.90M.
- Coeptis Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2020 was $0.00.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 7 month | Share-based Payment Arrangement, Noncash Expense 8 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 10 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|---|
| 2022-09-30 | $0.00 10-Q · filed 2022-11-08 | |||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $1.90M 10-K · filed 2022-03-11 | ||||
| 2021-09-30 | $1.90M 10-Q · filed 2022-11-08 | |||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $540.00K 10-KT · filed 2021-05-11 | $0.00 10-K · filed 2022-03-11 | |||
| 2020-11-30 | $479.00K 10-Q · filed 2021-01-11 | $480.33K 10-Q · filed 2021-01-11 | ||||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | |||||
| 2019-12-31 | $0.00 10-KT · filed 2021-05-11 | |||||
| 2019-11-30 | $0.00 10-Q · filed 2021-01-11 |